{"clinical_study": {"@rank": "1", "required_header": {"download_date": "ClinicalTrials.gov processed this data on June 05, 2014", "link_text": "Link to the current ClinicalTrials.gov record.", "url": "http://clinicaltrials.gov/show/NCT00000193"}, "id_info": {"org_study_id": "NIDA-00191-2", "secondary_id": ["K20DA000191", "K20-00191-2"], "nct_id": "NCT00000193"}, "brief_title": "Neurobiology of Opioid Dependence: 2 - 2", "official_title": "Neurobiology of Opioid Dependence: 2", "sponsors": {"lead_sponsor": {"agency": "Yale University", "agency_class": "Other"}, "collaborator": {"agency": "National Institute on Drug Abuse (NIDA)", "agency_class": "NIH"}}, "source": "Yale University", "oversight_info": {"authority": "United States: Federal Government"}, "brief_summary": {"textblock": "The purpose of this study is to evaluate the effects of gamma hydroxybutyric on\n      naloxone-precipitated opiate withdrawal."}, "overall_status": "Withdrawn", "start_date": "January 1993", "completion_date": {"@type": "Actual", "#text": "January 1998"}, "primary_completion_date": {"@type": "Actual", "#text": "January 1998"}, "phase": "Phase 2", "study_type": "Interventional", "study_design": "Masking: Double-Blind, Primary Purpose: Treatment", "primary_outcome": [{"measure": "Behavioral, subjective, measures of naloxone-preci"}, {"measure": "Phsyiological, neuroendocrine measures of naloxone"}], "enrollment": {"@type": "Actual", "#text": "0"}, "condition": "Opioid-Related Disorders", "intervention": {"intervention_type": "Drug", "intervention_name": "Gamma hydroxybutyric"}, "eligibility": {"criteria": {"textblock": "Please contact site for information."}, "gender": "Male", "minimum_age": "N/A", "maximum_age": "N/A", "healthy_volunteers": "No"}, "overall_official": {"last_name": "Marc I Rosen, M.D.", "role": "Principal Investigator", "affiliation": "VA Connecticut Healthcare System"}, "location": {"facility": {"name": "VA Connecticut Healthcare System", "address": {"city": "New Haven", "state": "Connecticut", "zip": "06519", "country": "United States"}}}, "location_countries": {"country": "United States"}, "verification_date": "September 2013", "lastchanged_date": "September 26, 2013", "firstreceived_date": "September 20, 1999", "responsible_party": {"responsible_party_type": "Sponsor"}, "has_expanded_access": "No", "condition_browse": {"mesh_term": "Opioid-Related Disorders"}, "intervention_browse": {"mesh_term": "Analgesics, Opioid"}}}